A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)
Status:
Completed
Trial end date:
2016-01-11
Target enrollment:
Participant gender:
Summary
This is an open-label, single sequence, 4-cycle, 4-treatment, drug-drug interaction (DDI)
study in healthy female subjects on oral contraceptives (OC). There is no formal research
hypothesis to be statistically tested. It is expected that coadministration of BMS-663068
with OC will not affect the pharmacokinetics (PK) of either ethinyl estradiol (EE) or
norethindrone (NE).